Previous studies in mice have provided evidence to support a model of the pathogenesis of AD, in which soluble Aβ oligomers trigger synaptic dysfunction; however, the formation of abnormal tau aggregates is required to induce neuronal death severe enough to result in cognitive decline and dementia. Here, MAPT is linked to Alzheimer disease.